Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

P Ashby

Showing results (141-150 of 228) with videos related to

Pageof 23
Sort By:
European Journal of Clinical Microbiology & Infectious Diseases : Official Publication of the European Society of Clinical Microbiology|June 1, 1989
Intraperitoneal penetration of cefpiromeJ Kavi, J P Ashby, R Wise, et al.
The Journal of Antimicrobial Chemotherapy|July 31, 2003
Determination of in vitro susceptibility to ABT-492 by BSAC standardized methodologyJ M Andrews, J P Ashby, G Jevons, et al.
Clinical Neurophysiology : Official Journal of the International Federation of Clinical Neurophysiology|November 25, 2000
Phase relationships between cortical and muscle oscillations in cortical myoclonus: electrocorticographic assessment in a single caseJ F Marsden, P Ashby, J C Rothwell, et al.
Neurology|August 1, 1994
Parietal Pick's disease mimicking cortical-basal ganglionic degenerationA E Lang, C Bergeron, M S Pollanen, et al.
Journal of Anatomy|November 15, 2006
18 Muscle and tendon pattern is altered independently of skeletal pattern in HoxD mutant limbsP Ashby, T Chinnah, J Zakany, et al.
The Journal of Antimicrobial Chemotherapy|March 3, 1999
The in-vitro activity of linezolid (U-100766) and tentative breakpointsR Wise, J M Andrews, F J Boswell, et al.
Antimicrobial Agents and Chemotherapy|May 1, 1988
In vitro activity of lomefloxacin, a new quinolone antimicrobial agent, in comparison with those of other agentsR Wise, J M Andrews, J P Ashby, et al.
British Journal of Pharmacology|July 1, 1976
Studies on the mechanism of action by which 5H-[1]-benzopyrano-[2,3,-b]-pyridin-5-ol (AH 6696) inhibits gastric acid secretion [proceedings]P Ashby, B P Curwain, M J Daly, et al.
Clinical Neurophysiology : Official Journal of the International Federation of Clinical Neurophysiology|June 11, 1999
On the focal nature of inhibition and facilitation in the human motor cortexP Ashby, C Reynolds, R Wennberg, et al.
The Biochemical Journal|December 15, 1978
Post-translational regulation of lipoprotein lipase activity in adipose tissueP Ashby, D P Bennett, I M Spencer, et al.
Pageof 23

Showing results (141-150 of 228) with videos related to

Sort By:
Pageof 23
European Journal of Clinical Microbiology & Infectious Diseases : Official Publication of the European Society of Clinical Microbiology|June 1, 1989
Intraperitoneal penetration of cefpiromeJ Kavi, J P Ashby, R Wise, et al.
The Journal of Antimicrobial Chemotherapy|July 31, 2003
Determination of in vitro susceptibility to ABT-492 by BSAC standardized methodologyJ M Andrews, J P Ashby, G Jevons, et al.
Clinical Neurophysiology : Official Journal of the International Federation of Clinical Neurophysiology|November 25, 2000
Phase relationships between cortical and muscle oscillations in cortical myoclonus: electrocorticographic assessment in a single caseJ F Marsden, P Ashby, J C Rothwell, et al.
Neurology|August 1, 1994
Parietal Pick's disease mimicking cortical-basal ganglionic degenerationA E Lang, C Bergeron, M S Pollanen, et al.
Journal of Anatomy|November 15, 2006
18 Muscle and tendon pattern is altered independently of skeletal pattern in HoxD mutant limbsP Ashby, T Chinnah, J Zakany, et al.
The Journal of Antimicrobial Chemotherapy|March 3, 1999
The in-vitro activity of linezolid (U-100766) and tentative breakpointsR Wise, J M Andrews, F J Boswell, et al.
Antimicrobial Agents and Chemotherapy|May 1, 1988
In vitro activity of lomefloxacin, a new quinolone antimicrobial agent, in comparison with those of other agentsR Wise, J M Andrews, J P Ashby, et al.
British Journal of Pharmacology|July 1, 1976
Studies on the mechanism of action by which 5H-[1]-benzopyrano-[2,3,-b]-pyridin-5-ol (AH 6696) inhibits gastric acid secretion [proceedings]P Ashby, B P Curwain, M J Daly, et al.
Clinical Neurophysiology : Official Journal of the International Federation of Clinical Neurophysiology|June 11, 1999
On the focal nature of inhibition and facilitation in the human motor cortexP Ashby, C Reynolds, R Wennberg, et al.
The Biochemical Journal|December 15, 1978
Post-translational regulation of lipoprotein lipase activity in adipose tissueP Ashby, D P Bennett, I M Spencer, et al.
Pageof 23